BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 23328732)

  • 1. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.
    Sanders LH; Timothy Greenamyre J
    Free Radic Biol Med; 2013 Sep; 62():111-120. PubMed ID: 23328732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.
    Ojha S; Javed H; Azimullah S; Haque ME
    Mol Cell Biochem; 2016 Jul; 418(1-2):59-70. PubMed ID: 27316720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.
    Tapias V; Cannon JR; Greenamyre JT
    Neurobiol Aging; 2014 May; 35(5):1162-76. PubMed ID: 24315037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tannic Acid Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Inflammation, Oxidative Stress, Apoptosis, and Glutamate Toxicity in Rats.
    Azimullah S; Meeran MFN; Ayoob K; Arunachalam S; Ojha S; Beiram R
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.
    Sanders LH; McCoy J; Hu X; Mastroberardino PG; Dickinson BC; Chang CJ; Chu CT; Van Houten B; Greenamyre JT
    Neurobiol Dis; 2014 Oct; 70():214-23. PubMed ID: 24981012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).
    Guo JD; Zhao X; Li Y; Li GR; Liu XL
    Int J Mol Med; 2018 Apr; 41(4):1817-1825. PubMed ID: 29393357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
    Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
    BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
    Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenothiazine normalizes the NADH/NAD
    Tapias V; McCoy JL; Greenamyre JT
    Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease.
    Chen Y; Zhang DQ; Liao Z; Wang B; Gong S; Wang C; Zhang MZ; Wang GH; Cai H; Liao FF; Xu JP
    Mol Neurodegener; 2015 Mar; 10():4. PubMed ID: 26013581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
    Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
    J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways.
    Jayaraj RL; Beiram R; Azimullah S; M F NM; Ojha SK; Adem A; Jalal FY
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
    Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
    Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
    Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
    Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
    Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.